Conventional wisdom says that having just one mutated copy of the cystic fibrosis gene has no effects on a person’s
Continue reading »
Home »
Research points to possible target to treat idiopathic pulmonary fibrosis, or IPF
Long-held dogma says lung fibrosis in diseases like idiopathic pulmonary fibrosis, or IPF, results from recurrent injury to alveolar epithelium
Continue reading »
In cystic fibrosis, lungs feed deadly bacteria
In cystic fibrosis, Pseudomonas aeruginosa is a much-feared pathogen. The bacterium easily colonizes the lungs of people with cystic fibrosis,
Continue reading »
Hinge-like protein may open new doors in cystic fibrosis treatment
In recent decades, treatment options for people with cystic fibrosis have improved dramatically. The newest drugs, known as potentiators, target
Continue reading »
Anti-reflux surgery promising in idiopathic pulmonary fibrosis
(HealthDay)—Laparoscopic antireflux surgery is safe and well-tolerated in patients with idiopathic pulmonary fibrosis (IPF) and abnormal acid gastroesophageal reflux (GER),
Continue reading »
Mechanism of fibrosis development discovered
Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease of unknown origin with limited treatment options. Research suggests that the
Continue reading »